Abiopharma

🔍 Millstreet Capital Management LLC (Executive)

Company: DIEBOLD NIXDORF, Inc (DBD)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 51,472 shares of Common Stock at $85.4314 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,765,271.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 60,833 shares of Common Stock at $84.7741 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,704,438.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Millstreet Capital Management LLC provides investment advisory services to private investment funds and accounts ("Accounts") and, in such capacity, may be deemed to beneficially own Common Shares held for the accounts of such Accounts. Mr. Connolly and Mr. Kelleher are Managing Members of Millstreet. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.